Brokerages Set Agilon Health, Inc. (NYSE:AGL) PT at $86.18

Posted by Brian Himes on Aug 20th, 2026

Agilon Health, Inc. (NYSE:AGL – Get Free Report) has received a consensus recommendation of “Hold” from the fourteen research firms that are presently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and five have given a buy rating to the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $91.30.

Several brokerages have recently commented on AGL. Jefferies Financial Group upgraded shares of Agilon Health from a “hold” rating to a “buy” rating and upped their price objective for the stock from $27.50 to $48.00 in a report on Thursday, May 7th. Benchmark reiterated a “buy” rating and issued a $140.00 target price (up from $95.00) on shares of Agilon Health in a report on Thursday, August 6th. Robert W. Baird set a $116.00 target price on Agilon Health in a research report on Thursday, August 6th. Weiss Ratings lowered Agilon Health from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, May 27th. Finally, Wall Street Zen upgraded Agilon Health from a “sell” rating to a “hold” rating in a research note on Saturday, May 9th.

Get Our Latest Research Report on AGL

Institutional Investors Weigh In On Agilon Health

Institutional investors and hedge funds have recently modified their holdings of the company. LPL Financial LLC boosted its holdings in Agilon Health by 213.4% during the 4th quarter. LPL Financial LLC now owns 44,055 shares of the company’s stock valued at $30,000 after acquiring an additional 30,000 shares during the period. Krilogy Financial LLC acquired a new position in Agilon Health in the 4th quarter valued at about $34,000. CIBC Bancorp USA Inc. purchased a new stake in Agilon Health during the third quarter worth about $34,000. Merit Financial Group LLC acquired a new stake in shares of Agilon Health during the fourth quarter worth about $35,000. Finally, Focus Partners Advisor Solutions LLC acquired a new stake in shares of Agilon Health during the fourth quarter worth about $53,000.

Agilon Health Stock Down 1.2%

Shares of AGL opened at $94.27 on Monday. The firm has a market cap of $1.58 billion, a P/E ratio of -6.61 and a beta of 3.01. Agilon Health has a 12-month low of $7.48 and a 12-month high of $133.04. The company’s 50-day moving average price is $106.62 and its 200 day moving average price is $60.12. The company has a current ratio of 1.08, a quick ratio of 1.08 and a debt-to-equity ratio of 0.07.

Agilon Health (NYSE:AGL – Get Free Report) last posted its earnings results on Wednesday, August 5th. The company reported $1.04 EPS for the quarter, beating analysts’ consensus estimates of $0.14 by $0.90. Agilon Health had a negative net margin of 3.92% and a negative return on equity of 119.38%. The company had revenue of $1.49 billion for the quarter, compared to analysts’ expectations of $1.45 billion. On average, sell-side analysts forecast that Agilon Health will post -2.95 earnings per share for the current year.

Agilon Health Company Profile

(Get Free Report)

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.